Eradicate Hepatitis C Virus: A pilot of treatment as prevention in active drug users
Phase of Trial: Phase IV
Latest Information Update: 10 May 2017
At a glance
- Drugs Simeprevir (Primary) ; Telaprevir (Primary) ; Peginterferon alfa; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms Eradicate HCV; ERADICATE Hep C; Eradicate-C
- 08 May 2017 Status changed from recruiting to completed.
- 21 Jun 2016 Planned End Date changed from 31 Aug 2015 to 31 Aug 2017.
- 24 Feb 2016 Planned number of patients changed from 100 to 200 as reported by United Kingdom Clinical Research Network record.